Published in Acta Trop on January 01, 2002
Domestic dogs and cats as sources of Trypanosoma cruzi infection in rural northwestern Argentina. Parasitology (2006) 1.79
Combined use of enzyme-linked immunosorbent assay and flow cytometry to detect antibodies to Trypanosoma cruzi in domestic canines in Texas. Clin Diagn Lab Immunol (2004) 0.98
Detection of Trypanosoma cruzi infection in naturally infected dogs and cats using serological, parasitological and molecular methods. Acta Trop (2013) 0.89
Unequivocal identification of subpopulations in putative multiclonal Trypanosoma cruzi strains by FACs single cell sorting and genotyping. PLoS Negl Trop Dis (2012) 0.83
Detection of cross infections by Leishmania spp. and Trypanosoma spp. in dogs using indirect immunoenzyme assay, indirect fluorescent antibody test and polymerase chain reaction. Parasitol Res (2012) 0.79
Revisiting the Posttherapeutic Cure Criterion in Chagas Disease: Time for New Methods, More Questions, Doubts, and Polemics or Time to Change Old Concepts? Biomed Res Int (2015) 0.78
Epidemiology and Molecular Typing of Trypanosoma cruzi in Naturally-Infected Hound Dogs and Associated Triatomine Vectors in Texas, USA. PLoS Negl Trop Dis (2017) 0.75
Hemoculture and Polymerase Chain Reaction Using Primers TCZ1/TCZ2 for the Diagnosis of Canine and Feline Trypanosomiasis. ISRN Vet Sci (2012) 0.75
Quality of life for people with dementia living in residential and nursing home care: the impact of performance on activities of daily living, behavioral and psychological symptoms, language skills, and psychotropic drugs. Int Psychogeriatr (2001) 1.96
Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun (2003) 1.81
Polymeric nonelectrolytes to probe pore geometry: application to the alpha-toxin transmembrane channel. Biophys J (1999) 1.53
Hemocultures for the parasitological diagnosis of human chronic Chagas' disease. Rev Soc Bras Med Trop (1990) 1.33
A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease. J Antimicrob Chemother (2000) 1.23
Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis. Eur J Pharmacol (2000) 1.21
Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int Immunol (1994) 1.16
Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand J Immunol (1996) 1.14
Experimental Chagas' disease in dogs. Mem Inst Oswaldo Cruz (1993) 1.12
Genital lesions associated with visceral leishmaniasis and shedding of Leishmania sp. in the semen of naturally infected dogs. Vet Pathol (2005) 1.08
Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity? Clin Exp Immunol (2006) 1.08
Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes. J Antimicrob Chemother (2004) 1.06
Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans. Infect Immun (2006) 1.05
Cytokines as determinants of resistance and pathology in human Schistosoma mansoni infection. Braz J Med Biol Res (1998) 1.05
Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization? Clin Exp Immunol (2007) 1.05
Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease. Scand J Immunol (2008) 1.04
Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes. Scand J Immunol (2005) 1.03
Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas' disease. Clin Diagn Lab Immunol (2001) 1.02
Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome. Scand J Immunol (2005) 1.00
Relationship between canine visceral leishmaniosis and the Leishmania (Leishmania) chagasi burden in dermal inflammatory foci. J Comp Pathol (2006) 0.99
Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi. Clin Exp Immunol (2006) 0.99
Canine visceral leishmaniosis: a remarkable histopathological picture of one case reported from Brazil. Vet Parasitol (2001) 0.98
The role of the immune response on the development of severe clinical forms of human Chagas disease. Mem Inst Oswaldo Cruz (1999) 0.98
Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats. Br J Pharmacol (2007) 0.97
Human Schistosomiasis mansoni: IL-10 modulates the in vitro granuloma formation. Parasite Immunol (1998) 0.97
Localized juvenile periodontitis and Actinobacillus actinomycetemcomitans in a Brazilian population. Eur J Oral Sci (1997) 0.97
Histopathological and immunohistochemical study of type 3 complement receptors (CD11b/CD18) in livers and spleens of asymptomatic and symptomatic dogs naturally infected with Leishmania (Leishmania) chagasi. Vet Immunol Immunopathol (2007) 0.96
Impact of Trypanosoma cruzi clonal evolution on its biological properties in mice. Exp Parasitol (2002) 0.92
Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile. Scand J Immunol (2006) 0.92
Humoral and cellular immune responses in dogs with inapparent natural Leishmania infantum infection. Vet J (2011) 0.92
Pathogenesis of lesions of the autonomic nervous system of the mouse in experimental acute Chagas' disease. Light and electron microscope studies. Am J Trop Med Hyg (1970) 0.92
Analysis of the effects of treatment of human Schistosoma mansoni infection on the immune response of patients from endemic areas. Acta Trop (2000) 0.91
Phenotypic features of peripheral blood leucocytes during early stages of human infection with Trypanosoma cruzi. Scand J Immunol (2003) 0.91
Histopathology and immunocytochemical study of type 3 and type 4 complement receptors in the liver and spleen of dogs naturally and experimentally infected with Leishmania (Leishmania) chagasi. Rev Inst Med Trop Sao Paulo (1997) 0.90
HLA class II alleles and chronic hepatitis C virus infection. Scand J Immunol (2011) 0.89
Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains. Mem Inst Oswaldo Cruz (2001) 0.88
[Myenteric plexus lesions in the esophagus, jejunum and colon of chronic chagasic patients. Electron microscopy study]. Rev Inst Med Trop Sao Paulo (1973) 0.88
Clinical and microbiological effects of adjunctive antibiotics in treatment of localized juvenile periodontitis. A controlled clinical trial. J Periodontol (1998) 0.88
In vivo wound healing effects of Symphytum officinale L. leaves extract in different topical formulations. Pharmazie (2012) 0.87
Light and electron microscope studies of the autonomic nervous system in experimental and human American trypanosomiasis. Virchows Arch A Pathol Pathol Anat (1971) 0.87
Clinical value of anti-live Leishmania (Viannia) braziliensis immunoglobulin G subclasses, detected by flow cytometry, for diagnosing active localized cutaneous leishmaniasis. Trop Med Int Health (2006) 0.87
Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes. J Antimicrob Chemother (2008) 0.87
[Comparative biological characterization of Berenice and Berenice-78 strains of Trypanosoma cruzi isolated from the same patient at different times]. Mem Inst Oswaldo Cruz (1987) 0.87
Evaluation of the influence of tissue parasite density on hematological and phenotypic cellular parameters of circulating leukocytes and splenocytes during ongoing canine visceral leishmaniasis. Parasitol Res (2008) 0.87
[Optical and electron microscopic study of the kidney of dogs naturally and experimentally infected with Leishmania (Leishmania) chagasi]. Rev Inst Med Trop Sao Paulo (1990) 0.86
Eosinophil recruitment into sites of delayed-type hypersensitivity reactions in mice. J Leukoc Biol (2001) 0.86
In vitro activity of hypnophilin from Lentinus strigosus: a potential prototype for Chagas disease and leishmaniasis chemotherapy. Braz J Med Biol Res (2010) 0.86
IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection. Clin Exp Immunol (2007) 0.85
Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection. Scand J Immunol (2008) 0.85
Comparison of acute physiology and chronic health evaluation II death risk, Child-Pugh, Charlson, and model for end-stage liver disease indexes to predict early mortality after liver transplantation. Transplant Proc (2011) 0.85
Posttherapeutic cure criteria in Chagas' disease: conventional serology followed by supplementary serological, parasitological, and molecular tests. Clin Vaccine Immunol (2012) 0.85
Influence of microbiota in experimental cutaneous leishmaniasis in Swiss mice. Rev Inst Med Trop Sao Paulo (1999) 0.85
Biological aspects of a Brazilian strain of Entamoeba dispar. Pathologica (2002) 0.85
Germ-free mice produce high levels of interferon-gamma in response to infection with Leishmania major but fail to heal lesions. Parasitology (2005) 0.85
Phenotypic study of peripheral blood leucocytes in HTLV-I-infected individuals from Minas Gerais, Brazil. Scand J Immunol (2002) 0.85
Trypanosoma cruzi: Impact of dual-clone infections on parasite biological properties in BALB/c mice. Exp Parasitol (2006) 0.84
Antigen F1 from Yersinia pestis forms aqueous channels in lipid bilayer membranes. Braz J Med Biol Res (1992) 0.84
Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs. Mem Inst Oswaldo Cruz (1998) 0.84
[Pathogenesis of Chagas' disease]. Rev Inst Med Trop Sao Paulo (1988) 0.83
Histopathology of human American cutaneous leishmaniasis before and after treatment. Rev Soc Bras Med Trop (1998) 0.83
Human papillomavirus infection in Brazilian women with normal cervical cytology. Genet Mol Res (2012) 0.83
Effect of heat and moisture exchangers on the prevention of ventilator-associated pneumonia in critically ill patients. Braz J Med Biol Res (2012) 0.83
Combined interleukin-12 and topical chemotherapy for established Leishmaniasis drastically reduces tissue parasitism and relapses in susceptible mice. J Infect Dis (2001) 0.83
Enalapril prevents cardiac immune-mediated damage and exerts anti-Trypanosoma cruzi activity during acute phase of experimental Chagas disease. Parasite Immunol (2010) 0.83
Chagas enteropathy. Gut (1973) 0.83
Trypanosoma cruzi: immunoglobulin isotype profiles during the acute phase of canine experimental infection with metacyclic or blood trypomastigotes. Exp Parasitol (2008) 0.83
Humoral immunological profile and parasitological statuses of Leishmune vaccinated and visceral leishmaniasis infected dogs from an endemic area. Vet Parasitol (2010) 0.82
Ageing and Toll-like receptor expression by innate immune cells in chronic human schistosomiasis. Clin Exp Immunol (2007) 0.82
Studies on the vesicular component of the Auerbach's plexus and the substance P content of the mouse colon in the acute phase of the experimental Trypanosoma cruzi infection. Virchows Arch A Pathol Anat Histol (1977) 0.81